Queries and epidemiologic studies. Develop and enhance the current cber capabilities with respect to electronic health data sources, infrastructure, methods, and tools and to conduct surveillance…
Ended Awarded Last action
- Contract number
- 75F40118F01001
- Awardee
-
Acumen LLC UEI XVMTJF1497P1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,888,103
Award facts
- Opportunity
-
- FDA18223SOL1196209 Solicitation number
- Contract value 100% obligated
- $2,888,103.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Hillsborough, CA 94010, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,888,103 |
About this award
This federal contract was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Acumen LLC, doing business as Medric, to develop and enhance the FDA's Center for Biologics Evaluation and Research (CBER) capabilities with respect to electronic health data sources, infrastructure, methods, and tools. The purpose is to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood and blood products, tissues, and advanced therapies. The contract has a potential value of $2,888,103.47 and is a Delivery Order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics, an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract is not set aside for any socioeconomic category.
Description
Queries and epidemiologic studies. Develop and enhance the current cber capabilities with respect to electronic health data sources, infrastructure, methods, and tools and to conduct surveillance and epidemiologic studies to assure the safety and effectiveness of biologic products including vaccines, blood and blood products, tissues and advanced therapeutics.
Quick answers
Who was awarded contract 75F40118F01001?
75F40118F01001 was awarded to Acumen LLC by Food and Drug Administration (Department of Health and Human Services) on September 24, 2018.
How much is contract 75F40118F01001 worth?
The government has obligated $2,888,103 on 75F40118F01001.
Is contract 75F40118F01001 an order under another contract?
Yes. 75F40118F01001 is a delivery order under 75F40118D10020, an indefinite delivery contract, on BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics.
Was contract 75F40118F01001 competed?
The extent of competition for 75F40118F01001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award